Sign in Register

Zevalin (In-111) (kit for prep indium-111/ibritumomab tiuxetan/albumin human)

Advertisement

Last reviewed · Source: First Databank (FDB) drug data

Overview

USES: This medication is combined with a certain radioactive substance (Yttrium-90) and used along with rituximab to treat a certain type of cancer (B-cell non-Hodgkin's lymphoma) in patients whose cancer has returned or has not responded to other treatments. Ibritumomab tiuxetan and rituximab are known as monoclonal antibodies. They work by killing certain blood and cancer cells from your immune system (B cells).

Yttrium-90 helps kill the cancer cells.

Generic name: kit for prep indium-111/ibritumomab tiuxetan/albumin human
Pronunciation: (EYE-bri-TOOM-oh-mab tye-UX-e-tan)

Reference product & biosimilars

No reference, biosimilar or interchangeable associated with this drug.

Today’s intelligence on Zevalin (In-111)

Intelligence content is not available yet.

Indications

The following indications are listed for Zevalin (In-111):

  • Follicular Lymphoma
  • Relapse Or Refractory Non-Hodgkin's Lymphoma

Also known as: Follicular B-Cell Lymphoma, Follicular B-Cell Non-Hodgkin's Lymphoma, Relapse Or Refractory Nhl.

Dosing

No dosing information is available for this tab.

Drug interactions

There is no enhanced messaging for this drug.

Contraindications

There is no enhanced messaging for this drug.

Adverse reactions

There is no enhanced messaging for this drug.

Precautions

No enhanced messaging available.

ICD codes

No ICD codes are available for this drug.

Formulary status

Search health-plan coverage for this drug by ZIP code.

Enter a 5-digit ZIP code. Searching does not change your profile.

Enter a ZIP code to view available health plans.

Last reviewed · Source: First Databank (FDB) drug data